1.
Da Roit F, Engelberts PJ, Taylor RP, Breij EC, Gritti G, Rambaldi A, Introna M, Parren PW, Beurskens FJ, Golay J. Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy. Haematologica [Internet]. 2014Dec.31 [cited 2026Nov.6];100(1):77-6. Available from: https://haematologica.org/article/view/7253